Premature senescence of the liver in Alagille patients

Abstract

Introduction

Alagille syndrome (ALGS) is an autosomal dominant disease characterized by a multisystem involvement including bile duct paucity and cholestasis, caused by JAG1 or NOTCH2 mutations in most of the cases. Jagged1-Notch2 interactions are known to be crucial for intrahepatic biliary tract development, but the Notch signaling pathway is also involved in the juxtacrine transmission of senescence and in the induction and modulation of the senescence-associated secretory phenotype (SASP).

Aim

Our aim was to investigate premature senescence and SASP in ALGS livers.

Methods

Liver tissue from ALGS patients was prospectively obtained at the time of liver transplantation (n = 5) and compared to control livers (n = 5).

Results

We evidenced advanced premature senescence in the livers of five JAG1 mutated ALGS pediatric patients through increased senescence-associated beta-galactosidase activity (p<0.05), increased p16 and p21 gene expression (p<0.01), and increased p16 and γH2AX protein expression (p<0.01). Senescence was located in hepatocytes of the whole liver parenchyma as well as in remaining bile ducts. The classical SASP markers TGF-β1, IL-6, and IL-8 were not overexpressed in the livers of our patients.

Conclusions

We demonstrate for the first time that ALGS livers display important premature senescence despite Jagged1 mutation, underlying the complexity of senescence and SASP development pathways.

Introduction

Alagille syndrome (ALGS) is an autosomal dominant disease characterized by a multisystem involvement including bile duct paucity and cholestasis. The penetrance is highly variable and clinical manifestations can also consist in cardiovascular defects, renal anomalies, characteristic facial features, vertebral arch/other skeletal defects and ocular features (typically posterior embryotoxon) [1]. In the presence of ALGS-related initial cholestasis, more than 75% of the patients need a liver transplantation before the age of 18 years [2]. A mutation in JAG1, which encodes the protein Jagged1, is associated with the phenotype in more than 90% of the cases. NOTCH2 mutations are found in up to 4% of the patients in the absence of JAG1 anomalies [2, 3]. Jagged1-Notch2 interactions are known to be crucial for intrahepatic biliary tract development [4]. The Notch signaling pathway also demonstrated to have major effects in senescence induction and propagation, especially through Notch1 [5]. Jagged1-Notch1 interactions induce a juxtacrine transmission of senescence and Notch1 mediates a switch between TGF-β-rich secretome and pro-inflammatory secretome during senescence [6]. Activation of Notch1 or Notch2 also induced premature senescence in vitro in human primary endothelial cells [7]. It was therefore relevant to investigate the presence of premature senescence and senescence-associated secretory phenotype (SASP) in ALGS livers.

Materials and methods

Liver samples

Five patients with genetically confirmed ALGS who underwent liver transplantation were prospectively recruited in the Pediatric Gastroenterology and Hepatology Unit of Cliniques Universitaires Saint-Luc between 2018 and 2022. A fragment of the explanted liver was collected during the surgery and biochemical data were obtained the day before the procedure. Five control liver fragments were provided by the Cliniques Universitaires Saint-Luc biobank when consent for research purposes was given. One control liver fragment was obtained from an explanted liver during liver transplantation for hyperoxaluria type 1 (metabolic defect in a structurally healthy liver), while the four others were obtained from diseased donors when the liver was not approved for liver transplantation (e.g. partially damaged organ) or when part of the liver was not transplanted due to surgical considerations. Biochemical data was not available for control patients. This project was approved by the Ethics Committee of Cliniques Universitaires Saint-Luc (registration number B403201938739). Written informed consent was obtained for all study participants.

Senescence-associated β-galactosidase activity assay

Senescence-associated β-galactosidase (SA-β-gal) activity assay was performed on cryopreserved liver tissue at pH 4 for one hour (37C) as previously described [8]. Stained sections were washed with PBS before performing immunohistochemical staining when indicated.

Immunohistochemistry

Five μm formalin-fixed paraffin-embedded (FFPE) liver sections were deparaffinized and rehydrated in xylene and graded alcohol series. After a 1 hour blocking step in 5% BSA (Merck, Darmstadt, Germany) ± 5% normal goat serum (Thermo Fisher Scientific, Waltham, MA, USA), sections were incubated at 37C with primary antibody for 1 hour (S1 Table in S1 File) followed by species-specific secondary antibodies incubation (Dako EnVision+ System HRP; Agilent, Santa Clara, CA, USA) and 3,3′-diaminobenzidine (DAB) chromogen detection. Digital quantification of staining was assessed on x20 magnification scanned sections by using the image analysis tool Author version 2017.2 (Visiopharm, Hørsholm, Denmark) as previously described [8].

Reverse transcription quantitative polymerase chain reaction

Liver homogenates were obtained from liver biopsies with the FastPrep-24 Classic Instrument (MP Biomedicals, Irvine, CA, USA). Total RNA was extracted from liver homogenates using Tripure isolation reagent (Roche, Basel, Switzerland) and retro-transcribed using the high-capacity cDNA reverse transcription kit (Applied Biosystems, Waltham, CA, USA). Quantitative PCR was carried out in duplicate using TaqMan universal MasterMix (Applied Biosystems) and pre-designed TaqMan probes (S2 Table in S1 File). Relative gene expression was determined with the ΔΔCt method using TBP and PPIA as housekeeping genes [9].

Statistical analysis

Statistical analysis was conducted using GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA, USA). Continuous variables were presented as mean ± standard deviation (SD). The non-parametric Mann-Whitney U test was used to compare continuous variables between subgroups. A two-tailed p-value < 0.05 was considered to indicate statistical significance for all analysis.

Results

Description of the study population is presented in Table 1. All the ALGS patients were transplanted at a pediatric age, while 2/5 controls were adults. All control liver tissues were structurally normal (no histological inflammation nor fibrosis). A heterozygous mutation of JAG1 was confirmed in all ALGS patients. Two patients were transplanted for end-stage liver disease with cirrhosis and portal hypertension, and three patients were transplanted due to poor quality of life mainly related to pruritus and jaundice, in the absence of established cirrhosis (Metavir F2-F3). Advanced premature senescence was evidenced in ALGS livers as demonstrated by an increase in p16 and γH2AX protein expression, as well as an increase in p16 and p21 gene expression (Figs 1 and 2A). However, gene expression of the SASP-associated markers TGF-β1, IL-6 and IL-8 was not increased in ALGS livers of our cohort (Fig 2B). One ALGS patient (patient number 5) had markedly increased liver gene expression of those three SASP markers, but we could not evidence any relevant clinical, biochemical or histological differences in this patient as compared to the four others except for the presence of hypoalbuminemia and marked hyperbilirubinemia (Table 1).

[Figure omitted. See PDF.]

Protein expression of γH2AX and p16 increases in ALGS livers as compared to controls. No significant change is observed regarding p21 protein expression. Liver sections from patient number 1 and control number 3 were used as representative images. ALGS: Alagille syndrome; DAB: 3,3′-diaminobenzidine. Data is presented as mean ± SD; **p<0.01. Scale bars = 100 μm.

[Figure omitted. See PDF.]

(A) Gene expression of p21 and p16 increases in ALGS livers. (B) Gene expression of SASP markers TGF-β1, IL-6 and IL-8 is unchanged in ALGS livers. ALGS: Alagille syndrome; SASP: senescence-associated secretory phenotype. Data is presented as mean ± SD; **p<0.01.

[Figure omitted. See PDF.]

SA-β-gal activity confirmed the presence of senescence in ALGS livers (Fig 3A). Concomitant staining of SA-β-gal activity and CK-19 immunohistochemistry revealed the presence of senescence in the whole liver parenchyma and pointed out the disappearance of bile ducts in ALGS livers (Fig 3B). However, the remaining bile ducts were senescent as well as demonstrated by serial immunostaining of p16 and CK-19 (Fig 3C). Of note, levels of senescence appeared comparable between adult and pediatric control livers, as expected since cholangiocytes and hepatocytes do not suffer from telomere shortening and replicative senescence until late in life in physiological conditions (Figs 1–3) [10].

[Figure omitted. See PDF.]

(A) SA-β-gal activity increases in ALGS livers as compared to controls. (B) Concomitant staining of SA-β-gal activity and CK-19 IHC shows senescence in the whole liver parenchyma of ALGS livers, with disappearance of intrahepatic bile ducts as demonstrated by the absence of CK-19 immunostaining on this liver section. (C) Serial immunostaining of p16 and CK-19 evidences senescence in the remaining bile ducts of ALGS livers. Liver sections from patient number 2 and control number 2 were used as representative images. ALGS: Alagille syndrome; IHC: immunohistochemistry; SA-β-gal: senescence-associated beta-galactosidase. Data is presented as mean ± SD; *p<0.05. Scale bars = 100 μm.

Finally, we investigated the expression of senescence and SASP-related genes in a published RNA sequencing dataset from Andersson et al, obtained from pediatric ALGS (n = 5) and cholestatic (n = 2)/non-cholestatic (n = 2) control livers (GSE104873) [11]. We only considered the results of the differential expression analysis comparing ALGS to non-cholestatic controls since oxidative stress due to bile acids accumulation can per se lead to premature senescence in cholestatic diseases [12]. Also, ALGS and cholestatic livers clustered together in the principal component analysis of the study and were distinct from the transcriptomes of the two non-cholestatic controls suffering from autoimmune hepatitis [11]. Amongst the 370 genes that were upregulated in the differential expression analysis of ALGS livers versus non-cholestatic controls, 14 genes were previously described as SASP components, including CXCL8 (IL-8) (Table 2) [13–15]. Only 2/5 ALGS patients had a marked upregulation of all the 14 SASP-related genes. CDKN1A (p21), CDKN2A (p16), TGFB1 (TGF-β1) and IL6 (IL-6) were not significantly upregulated in the differential expression analysis, but seemed overexpressed in some ALGS patients when the detailed database was investigated. Those observations underlie the heterogeneity of senescence and SASP-related transcriptomes in ALGS patients.

[Figure omitted. See PDF.]

Discussion

Our results demonstrate for the first time that JAG1 mutated livers from patients with ALGS display advanced premature senescence from early life. Senescence is located in the whole liver parenchyma, and predominates in hepatocytes in the presence of a major intrahepatic ductular paucity inherent to the disease. Our observations are in line with the increased SA-β-gal activity that was evidenced in livers from jag1b/2b mutants zebrafish (jag1b^-/-; jag2b^-/-), in which the developmental loss of intrahepatic cholangiocytes and the subsequent cholestasis of ALGS are phenocopied [16]. Due to Jagged1 mutation, an impairment of the juxtacrine transmission of senescence mediated by Jagged1-Notch1 interactions would be expected in ALGS [6]. Jagged1 deficiency might also affect the transient increase in Notch1 and in the active Notch1 intracellular domain (N1ICD) necessary to induce the TGF-β1-rich primary SASP, TGF-β being an important promotor of the paracrine transmission of senescence in liver disease [6, 17, 18]. This transient increase is normally followed by N1ICD downregulation, which allows the production of a pro-inflammatory SASP containing inflammatory cytokines such as IL-6 and IL-8 through the de-repression of C/EBPβ [5]. The SASP markers TGF-β1, IL-6 and IL-8 were not overexpressed in ALGS livers in our cohort–except for one patient–and TGF-β1 was not differentially expressed in ALGS versus control livers in a published RNA sequencing dataset [11]. Jagged1/Notch/TGF-β-independent mechanisms are therefore involved in the important premature senescence that we observe in ALGS livers, in the absence of the classically described mechanisms of juxtacrine and paracrine transmission of senescence. We indeed observed that other SASP components promoting the paracrine transmission of senescence such as CCL2 and CCL20 were upregulated in ALGS livers RNA sequencing dataset, corroborating the fact that other senescence pathways might compensate the abnormal Notch signaling [11, 19, 20]. Also, we observed an important interpatient variability regarding the expression of senescence and SASP-related genes in our cohort and in a published dataset of ALGS livers. The senescence and SASP profiles can vary widely according to the cell type, senescence-inducing stress and duration of senescence, but the interpatient variability that we observed could also be related to the high phenotypic variability inherent to ALGS [15]. Finally, senescence markers were expressed to various extent within one patient, corroborating the fact that the analysis of a combination of markers is mandatory for an accurate evaluation of the senescent phenotype [21]. Further studies will be needed to deeply investigate pathways involved in senescence and SASP regulation, especially due to the small number of patients included in this preliminary study along with high interpatient variability. In particular, comparing JAG1- and NOTCH2-mutated ALGS livers could be of high interest to discriminate Notch1 and Notch2 involvement in senescence and SASP. In conclusion, ALGS livers display important premature senescence despite Jagged1 mutation, underlying the complexity of senescence and SASP development pathways.

Supporting information

S1 File. Supplementary tables.

This file contains the S1 (primary antibodies) and S2 Tables (pre-designed TaqMan probes).

https://doi.org/10.1371/journal.pone.0285019.s001

(DOCX)

S2 File. Dataset.

This file contains the dataset underlying the results described in our manuscript.

https://doi.org/10.1371/journal.pone.0285019.s002

(XLSX)

Acknowledgments

We thank the IREC 2IP platform for the use of laboratory facilities, and especially Caroline Bouzin for designing the Visiopharm APPs necessary for the digital quantification of histological staining. Giulia Jannone, Catherine de Magnée, Roberto Tambucci and Etienne Sokal are members of the European Reference Networks Rare-Liver and/or TransplantChild.

Citation: Jannone G, de Magnée C, Tambucci R, Evraerts J, Ravau J, Najimi M, et al. (2023) Premature senescence of the liver in Alagille patients. PLoS ONE 18(4): e0285019. https://doi.org/10.1371/journal.pone.0285019

About the Authors:

Giulia Jannone

Roles: Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

E-mail: [email protected]

Affiliation: Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium

ORICD: https://orcid.org/0000-0002-7452-8727

Catherine de Magnée

Roles: Data curation, Writing – review & editing

Affiliation: Pediatric Surgery and Transplantation Unit, Department of Surgery, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium

Roberto Tambucci

Roles: Data curation, Writing – review & editing

Affiliation: Pediatric Surgery and Transplantation Unit, Department of Surgery, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium

Jonathan Evraerts

Roles: Data curation, Formal analysis, Writing – review & editing

Affiliation: Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium

Joachim Ravau

Roles: Data curation, Formal analysis, Writing – review & editing

Affiliation: Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium

Mustapha Najimi

Roles: Conceptualization, Supervision, Writing – review & editing

Affiliation: Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium

ORICD: https://orcid.org/0000-0002-7329-9635

Etienne Marc Sokal

Roles: Conceptualization, Supervision, Writing – review & editing

Affiliation: Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, Brussels, Belgium

References

1. Ayoub MD, Kamath BM. Alagille Syndrome: Diagnostic Challenges and Advances in Management. Diagnostics (Basel). 2020;10(11). pmid:33172025

2. Kamath BM, Ye W, Goodrich NP, Loomes KM, Romero R, Heubi JE, et al. Outcomes of Childhood Cholestasis in Alagille Syndrome: Results of a Multicenter Observational Study. Hepatol Commun. 2020;4(3):387–98. pmid:33313463

3. Gilbert MA, Bauer RC, Rajagopalan R, Grochowski CM, Chao G, McEldrew D, et al. Alagille syndrome mutation update: Comprehensive overview of JAG1 and NOTCH2 mutation frequencies and insight into missense variant classification. Hum Mutat. 2019;40(12):2197–220. pmid:31343788

4. Lemaigre FP. Development of the Intrahepatic and Extrahepatic Biliary Tract: A Framework for Understanding Congenital Diseases. Annu Rev Pathol. 2020;15:1–22. pmid:31299162

5. Ito Y, Hoare M, Narita M. Spatial and Temporal Control of Senescence. Trends Cell Biol. 2017;27(11):820–32. pmid:28822679

6. Hoare M, Ito Y, Kang TW, Weekes MP, Matheson NJ, Patten DA, et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat Cell Biol. 2016;18(9):979–92. pmid:27525720

7. Venkatesh D, Fredette N, Rostama B, Tang Y, Vary CP, Liaw L, et al. RhoA-mediated signaling in Notch-induced senescence-like growth arrest and endothelial barrier dysfunction. Arterioscler Thromb Vasc Biol. 2011;31(4):876–82. pmid:21273559

8. Jannone G, Rozzi M, Najimi M, Decottignies A, Sokal EM. An Optimized Protocol for Histochemical Detection of Senescence-associated Beta-galactosidase Activity in Cryopreserved Liver Tissue. J Histochem Cytochem. 2020:22155420913534. pmid:32154749

9. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. pmid:11846609

10. Verma S, Tachtatzis P, Penrhyn-Lowe S, Scarpini C, Jurk D, Von Zglinicki T, et al. Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver. Hepatology. 2012;56(4):1510–20. pmid:22504828

11. Andersson ER, Chivukula IV, Hankeova S, Sjoqvist M, Tsoi YL, Ramskold D, et al. Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations. Gastroenterology. 2018;154(4):1080–95. pmid:29162437

12. Meadows V, Baiocchi L, Kundu D, Sato K, Fuentes Y, Wu C, et al. Biliary Epithelial Senescence in Liver Disease: There Will Be SASP. Front Mol Biosci. 2021;8:803098. pmid:34993234

13. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010;16(5):238–46. pmid:20444648

14. Irvine KM, Skoien R, Bokil NJ, Melino M, Thomas GP, Loo D, et al. Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration. World J Gastroenterol. 2014;20(47):17851–62. pmid:25548483

15. Hernandez-Segura A, de Jong TV, Melov S, Guryev V, Campisi J, Demaria M. Unmasking Transcriptional Heterogeneity in Senescent Cells. Curr Biol. 2017;27(17):2652–60 e4. pmid:28844647

16. Zhao C, Lancman JJ, Yang Y, Gates KP, Cao D, Barske L, et al. Intrahepatic cholangiocyte regeneration from an Fgf-dependent extrahepatic progenitor niche in a zebrafish model of Alagille Syndrome. Hepatology. 2022;75(3):567–83.

17. Bird TG, Muller M, Boulter L, Vincent DF, Ridgway RA, Lopez-Guadamillas E, et al. TGFbeta inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence. Sci Transl Med. 2018;10(454).

18. Ferreira-Gonzalez S, Lu WY, Raven A, Dwyer B, Man TY, O’Duibhir E, et al. Paracrine cellular senescence exacerbates biliary injury and impairs regeneration. Nat Commun. 2018;9(1):1020. pmid:29523787

19. Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978–90. pmid:23770676

20. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis. J Hepatol. 2010;53(2):318–25. pmid:20570384

21. Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, et al. Cellular Senescence: Defining a Path Forward. Cell. 2019;179(4):813–27. pmid:31675495